Receive in-depth updates on the latest in GI and hepatology, endoscopy, and practice management when you attend one or more of the optional Friday courses. Four courses are offered: two half-day courses, the GI Pathophysiology Course and the What’s New in GI Pharmacology Course; and two full-day courses, the Practice Management Course and the ASGE Endoscopy Course.
Attending the Postgraduate Course? Register for the GI Pathophysiology and the What’s New in GI Pharmacology Courses and save up to 10 percent! The GI Pathophysiology Course, the What’s New in GI Pharmacology Course, along with the Postgraduate Course make up the Three-Day Clinical Review, your comprehensive clinical update.
Course Directors: Brooks D. Cash, MD, FACG, and William D. Chey, MD, FACG
Experts will define and describe the use and management of new pharmacological therapies as well as provide updates on current pharmacological treatment options for a variety of GI disorders during the What’s New in GI Pharmacology Course.
Save up to 10% when you register for the Three-Day Clinical Review!
|Friday, October 25, 2019 | 1:45 pm – 5:15 pm|
|1:45 pm||Welcome and Introductions
Brooks D. Cash, MD, FACG, and William D. Chey, MD, FACG
|1:50 pm||New Concepts in the Treatment of Eosinophilic Esophagitis
Evan S. Dellon, MD, MPH, FACG
Review recent updates in the epidemiology, nomenclature, diagnostic processes, and management of eosinophilic esophagitis.
|2:10 pm||Jump-Starting Gastroparesis
Michael Camilleri, MD, FACG
Discuss the diagnosis of gastroparesis in a variety of clinical scenarios, and review current and emerging pharmacologic options for the management of gastroparesis symptoms.
|2:30 pm||Primary and Salvage Therapies for H. pylori
William D. Chey, MD, FACG
Describe the recently-updated ACG guidelines for the management of H. pylori-related disease and review current therapeutic approaches to H. pylori eradication.
|2:50 pm||Gastroprotection and the Renaissance of Peptic Ulcer Bleeding: Who Needs It and Who Doesn’t
John R. Saltzman, MD, FACG
Identify the evidence for and against the use of gastrointestinal prophylaxis for peptic ulcer disease in patients with systemic disease associated with increased risk of gastrointestinal complications.
|3:10 pm||Q & A|
|3:40 pm||Contemporary Approach to SIBO and Bloating
Linda Anh B. Nguyen, MD
Discuss current and emerging diagnostic and treatment options for small intestinal bacterial overgrowth and bloating.
|4:00 pm||Medical Therapies for Crohn's Disease: What to Start With and When to Change
Millie D. Long, MD, MPH, FACG
Describe the evidence for when to employ different medical therapies available for Crohn’s disease and review algorithms for altering medical management when necessary.
|4:20 pm||Autoimmune Hepatitis: When to Move Beyond Steroids
Steven L. Flamm, MD, FACG
Review the diagnostic varieties of AIH and provide recommendations for appropriate medical approaches for the various AIH forms.
|4:40 pm||How and When to Use Neuromodulators for Functional Upper and Lower GI Syndromes
Brooks D. Cash, MD, FACG
Explain the rationale, evidence, and outcomes associated with neuromodulators for patients with functional dyspepsia, non-cardiac chest pain, and irritable bowel syndrome.
|5:00 pm||Q & A|
|5:15 pm||What's New in GI Pharmacology Course Adjourns|